Julie Liu Joins Cerecin From Pfizer as New Vice President of R&D and Chemicals, Manufacturing and Controls
04 févr. 2021 06h00 HE
|
Cerecin
Colorado USA, Melbourne Australia, and Singapore, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Cerecin, Inc. a clinical-stage biotechnology company pioneering ketogenic neurotherapeutics, today announced the...
Cerecin Announces Orphan Drug Designation from U.S. FDA for Tricaprilin in the Treatment of Infantile Spasms
29 oct. 2020 08h00 HE
|
Cerecin
SINGAPORE AND DENVER, COLORADO, Oct. 29, 2020 (GLOBE NEWSWIRE) -- Cerecin, a biopharmaceutical company focused on discovering and developing brain therapeutics, announced today that the U.S. Food...
U.S. FDA Grants Rare Pediatric Disease Designation to Cerecin’s Investigational Drug Tricaprilin for the Treatment of Infantile Spasms
08 oct. 2020 04h48 HE
|
Cerecin
SINGAPORE AND DENVER, COLORADO , Oct. 08, 2020 (GLOBE NEWSWIRE) -- Cerecin, a biopharmaceutical company focused on discovering and developing brain therapeutics, announced that the U.S. Food and...
Cerecin appoints biotech veteran Joseph S. Zakrzewski as its new Chairman
20 déc. 2019 05h15 HE
|
Cerecin
SINGAPORE AND DENVER, COLORADO, Dec. 20, 2019 (GLOBE NEWSWIRE) -- SINGAPORE AND DENVER, COLORADO, 20 December 2019 – Cerecin, an innovative biopharmaceutical company focused on brain health, today...
Cerecin strengthens its leadership position in CNS drug development by adding a biotech veteran to the executive team Bruce Morimoto joins Cerecin as Vice President of Drug Development
04 nov. 2019 05h00 HE
|
Cerecin
Denver, Colorado, Nov. 04, 2019 (GLOBE NEWSWIRE) -- Cerecin, a global healthcare company focused on developing brain health solutions and therapeutics for patients around the world, today announced...
Cerecin appoints Dr. Xiaoping Cao as Head of CMC
07 janv. 2019 02h00 HE
|
Cerecin
Singapore, Jan. 07, 2019 (GLOBE NEWSWIRE) -- Cerecin appoints Dr. Xiaoping Cao as Head of CMC Dr. Cao will lead the Chemistry, Manufacturing and Controls (CMC) of Cerecin’s pipeline of highly...